State Street’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.6K | Sell |
124,232
-594,621
| -83% | -$247K | ﹤0.01% | 4089 |
|
|
2025
Q1 | $448K | Buy |
718,853
+34,730
| +5% | +$21.6K | ﹤0.01% | 3620 |
|
|
2024
Q4 | $1.14M | Buy |
684,123
+12,747
| +2% | +$21.3K | ﹤0.01% | 3461 |
|
|
2024
Q3 | $1.22M | Sell |
671,376
-34,171
| -5% | -$62.2K | ﹤0.01% | 3450 |
|
|
2024
Q2 | $4.25M | Buy |
705,547
+151,680
| +27% | +$915K | ﹤0.01% | 2994 |
|
|
2024
Q1 | $6.18M | Buy |
553,867
+52,371
| +10% | +$584K | ﹤0.01% | 2836 |
|
|
2023
Q4 | $7.47M | Buy |
501,496
+112,137
| +29% | +$1.67M | ﹤0.01% | 2740 |
|
|
2023
Q3 | $1.87M | Buy |
389,359
+7,940
| +2% | +$38.1K | ﹤0.01% | 3364 |
|
|
2023
Q2 | $2.86M | Sell |
381,419
-12,525
| -3% | -$94.1K | ﹤0.01% | 3247 |
|
|
2023
Q1 | $1.78M | Buy |
393,944
+394
| +0.1% | +$1.78K | ﹤0.01% | 3378 |
|
|
2022
Q4 | $4.44M | Buy |
393,550
+8,987
| +2% | +$101K | ﹤0.01% | 3084 |
|
|
2022
Q3 | $3.68M | Buy |
384,563
+28,758
| +8% | +$275K | ﹤0.01% | 3207 |
|
|
2022
Q2 | $2.88M | Sell |
355,805
-1,777,939
| -83% | -$14.4M | ﹤0.01% | 3352 |
|
|
2022
Q1 | $36.1M | Buy |
2,133,744
+691,410
| +48% | +$11.7M | ﹤0.01% | 1962 |
|
|
2021
Q4 | $31M | Buy |
1,442,334
+580,779
| +67% | +$12.5M | ﹤0.01% | 2152 |
|
|
2021
Q3 | $63.6M | Sell |
861,555
-193,322
| -18% | -$14.3M | ﹤0.01% | 1624 |
|
|
2021
Q2 | $57.7M | Buy |
1,054,877
+127,438
| +14% | +$6.97M | ﹤0.01% | 1744 |
|
|
2021
Q1 | $68.4M | Buy |
927,439
+544,900
| +142% | +$40.2M | ﹤0.01% | 1515 |
|
|
2020
Q4 | $33M | Buy |
382,539
+269,016
| +237% | +$23.2M | ﹤0.01% | 1914 |
|
|
2020
Q3 | $4.28M | Buy |
+113,523
| New | +$4.28M | ﹤0.01% | 2855 |
|